What smart money is saying about LeMaitre Vascular, Inc.
LMAT
No fund has written a full thesis on LeMaitre Vascular, Inc. in our archive, but 2 fund letters report a position in it — most recently Riverwater Partners Micro Opportunities Strategy in June 2026.
Get an email when a fund writes about it
2
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Every position in LeMaitre Vascular, Inc. on record in the archive was reported in Q2 2026, across 2 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 2 | 0 | 0 | 0 |
Fund activity · 2 positions
- June 2026
Listed in Riverwater Partners Micro Opportunities Strategy’s reported holdings.
Read the letterLeMaitre Vascular, Inc. - June 2026
“LeMaitre Vascular (LMAT) LeMaitre Vascular, our peripheral vascular device holding, declined approximately 12% in a quarter when nearly everything profitable in small cap health care went down and nearly everything speculative went up.”
Read the letterLeMaitre Vascular, Inc.
Read the letters behind these LeMaitre Vascular, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger